CCL5 and cancer: For example, in pancreatic ductal adenocarcinoma (PDAC), Wang et al. found that FOXP3-positive cancer cells secreted CCL5 to recruit Tregs into the TME, which can be blocked to repress Treg influx and tumour growth71.